SCHEMBL8902603

SCHEMBL8902603

CCC1OC(C(=O)O)CC2=C1C(=O)c1c(cc3ccccc3c1OC(C)=O)C2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.36
CTH P32929 1/20 0.33
ADORA3 P0DMS8 2/20 0.32
ADORA2A P29274 2/20 0.32
ADORA1 P30542 2/20 0.32
DNMT3B Q9UBC3 1/20 0.32
HSP90AA1 P07900 1/20 0.32
PAX8 Q06710 1/20 0.32
KDM4E B2RXH2 3/20 0.31
ALDH1A1 P00352 2/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
APEX1 P27695 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8902846 0.96 AKT1 (0.33) AKT1ADORA3ADORA2AADORA1KDM4E
SCHEMBL8902823 0.88 IDO1 (0.39) AKT1CTHADORA3ADORA2AADORA1
SCHEMBL8903882 0.88 AKT1 (0.36) AKT1CTHDNMT3BHSP90AA1PAX8
SCHEMBL8901515 0.86 AKT1 (0.41) AKT1CTHDNMT3BHSP90AA1PAX8
SCHEMBL8902595 0.84 CTH (0.36) AKT1CTHADORA3ADORA2AADORA1
SCHEMBL8903434 0.83 AKT1 (0.35) AKT1DNMT3BHSP90AA1PAX8KDM4E
SCHEMBL8901803 0.83 AKT1 (0.35) AKT1DNMT3BHSP90AA1PAX8KDM4E
SCHEMBL8903519 0.80 NR1D1 (0.33) CTHADORA3ADORA2AADORA1KDM4E
SCHEMBL8903221 0.80 NR1D1 (0.33) CTHADORA3ADORA2AADORA1KDM4E
SCHEMBL9755764 0.80 ADORA3 (0.35) ADORA3ADORA2AADORA1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed